Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML

Elspeth M. Payne, Niccolò Bolli, Jennifer Rhodes, Omar I. Abdel-Wahab, Ross Levine, Cyrus V. Hedvat, Richard Stone, Arati Khanna-Gupta, Hong Sun, John P. Kanki, Hanna T. Gazda, Alan H. Beggs, Finbarr E. Cotter, A. Thomas Look

Blood (2011) 118 (4): 903–915.

https://doi.org/10.1182/blood-2010-11-318022

Published: 2011

Includes: Multimedia, Supplemental data

Journal Articles

GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death

Matthew J. Streetly, Lenushka Maharaj, Simon Joel, Steve A. Schey, John G. Gribben, Finbarr E. Cotter

Blood (2010) 115 (19): 3939–3948.

https://doi.org/10.1182/blood-2009-10-251660

Published: 2010

Journal Articles

GCS-100 Targets Apoptosis and Cell Cycle Regulation in Myeloma Cells.

Matthew Streetly, BMBS, MRCP, MRCPath, Lenushka Maharaj, Simon P Joel, Finbarr E Cotter, FRCP, FRCPath, PhD

Blood (2009) 114 (22): 4923.

https://doi.org/10.1182/blood.V114.22.4923.4923

Published: 2009

Journal Articles

Mcl-1, Bcl-x L and Cell Cycle Inhibition by GCS-100: A Novel Therapy for Myeloma.

Matthew Streetly, Bo Su, Bradley Carver, Stephen A. Schey, Finbarr E. Cotter

Blood (2006) 108 (11): 3471.

https://doi.org/10.1182/blood.V108.11.3471.3471

Published: 2006

Journal Articles

The 13q and 11q B-Cell Chronic Lymphocytic Leukemia Deleted Regions Derive from a Common Ancestral Region in the Zebrafish on Linkage Group 9.

Rebecca L. Auer, MD, PhD, Sophia Riaz, BSc, Finbarr E. Cotter, MD PhD

Blood (2006) 108 (11): 295.

https://doi.org/10.1182/blood.V108.11.295.295

Published: 2006

Journal Articles

Dynamic Assessment of Apoptosis for In Vitro Design of Bortezomib Combination Therapies for Lymphoid Malignancies.

Lauren C. Wallis, BSc, Matthew J. Streetly, BM, BS, Rebecca Auer, PhD, John Gribben, PhD, Dean Zhang, PhD, William D. Hankins, PhD, Siroos Mehdi Zadeh, PhD, Finbarr E. Cotter, PhD

Blood (2006) 108 (11): 2494.

https://doi.org/10.1182/blood.V108.11.2494.2494

Published: 2006

Journal Articles

Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome

Jürgen Groet, Claire Mulligan, Monica Spinelli, Anna Serra, Suzanne McElwaine, Finbarr E. Cotter, Franca Dagna-Bricarelli, Giuseppe Saglio, Giuseppe Basso, Dean Nizetic

Blood (2005) 106 (5): 1887–1888.

https://doi.org/10.1182/blood-2005-03-1071

Published: 2005

Journal Articles

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Finbarr E. Cotter, MD PhD, Bo Su, MD, Margherita Corbo, BSc, Y. Chang, Joanne Schindler, Brad Carver, Christopher D. Fegan, MD, Adrian C. Newland, MD, Rebecca L. Auer, MD PhD

Blood (2004) 104 (11): 3286.

https://doi.org/10.1182/blood.V104.11.3286.3286

Published: 2004

Journal Articles

Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells

Dharminder Chauhan, Guilan Li, Klaus Podar, Teru Hideshima, Constantine Mitsiades, Robert Schlossman, Nikhil Munshi, Paul Richardson, Finbarr E. Cotter, Kenneth C. Anderson

Blood (2004) 104 (8): 2458–2466.

https://doi.org/10.1182/blood-2004-02-0547

Published: 2004

Journal Articles

Molecular follow-up in gastric mucosa–associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial

Francesco Bertoni, Annarita Conconi, Carlo Capella, Teresio Motta, Roberto Giardini, Maurilio Ponzoni, Ennio Pedrinis, Domenico Novero, Paolo Rinaldi, Giovanni Cazzaniga, Andrea Biondi, Andrew Wotherspoon, Barry William Hancock, Paul Smith, Robert Souhami, Finbarr E. Cotter, Franco Cavalli, Emanuele Zucca

Blood (2002) 99 (7): 2541–2544.

https://doi.org/10.1182/blood.V99.7.2541

Published: 2002

Journal Articles

Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia

Rebecca L. Auer, Christopher Jones, Roman A. Mullenbach, Denise Syndercombe-Court, Donald W. Milligan, Christopher D. Fegan, Finbarr E. Cotter

Blood (2001) 97 (2): 509–515.

https://doi.org/10.1182/blood.V97.2.509

Published: 2001

NARROW

Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML

GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death

GCS-100 Targets Apoptosis and Cell Cycle Regulation in Myeloma Cells.

Mcl-1, Bcl-x L and Cell Cycle Inhibition by GCS-100: A Novel Therapy for Myeloma.

The 13q and 11q B-Cell Chronic Lymphocytic Leukemia Deleted Regions Derive from a Common Ancestral Region in the Zebrafish on Linkage Group 9.

Dynamic Assessment of Apoptosis for In Vitro Design of Bortezomib Combination Therapies for Lymphoid Malignancies.

Independent clones at separable stages of differentiation, bearing different GATA1 mutations, in the same TMD patient with Down syndrome

GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.

Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells

Molecular follow-up in gastric mucosa–associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial

Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only